How Did Humans Get HIV? The Scientific Origin Story

HIV entered the human population through contact with the blood of infected primates in central and west Africa, almost certainly during the hunting and butchering of wild apes and monkeys. Genetic detective work over the past three decades has traced HIV-1, the virus responsible for the global pandemic, to chimpanzees in a narrow region of southeastern Cameroon, while HIV-2, a less widespread relative, descended from a different virus carried by sooty mangabeys in West Africa. But how the virus first landed in a human body is only part of the story. A chain of social, medical, and demographic upheavals in colonial-era Africa turned what would otherwise have been a dead-end infection into the defining pandemic of the twentieth century.

Which Primates Gave Us Which Viruses

HIV is not one virus with one origin. It arrived in humans through at least four separate spillover events, each traceable to a specific primate host and a specific region. The distinctions matter because they explain why the pandemic took the shape it did.

HIV-1, the virus behind the global AIDS epidemic, belongs to several groups designated M, N, O, and P. Groups M and N both trace back to simian immunodeficiency virus strains circulating in wild chimpanzees (Pan troglodytes troglodytes) in southern Cameroon, where some chimpanzee communities carry infection rates as high as 29 to 35 percent.¹ Phylogenetic analysis of these chimpanzee viruses shows that the ancestor of group M, the pandemic strain responsible for more than 90 percent of HIV infections worldwide, came from a relatively isolated cluster of chimpanzees in the southeastern corner of Cameroon.² Group N came from a geographically separate chimpanzee community and has remained extremely rare, infecting only a handful of people.

Groups O and P, meanwhile, came not from chimpanzees but from western lowland gorillas. Genomic comparisons of gorilla SIV strains in central Cameroon showed that one was very closely related to HIV-1 group O, which has spread epidemically in west central Africa and infected an estimated 100,000 people.³ Group P, discovered in 2009, also appears to have a gorilla origin and has been found in only two individuals. The gorillas themselves likely acquired their SIV from chimpanzees before passing it to humans, making the chain of transmission longer than it first appears.

HIV-2 has an entirely separate history. It descends from SIV strains native to sooty mangabeys, small monkeys widespread across West Africa.⁴ Unlike HIV-1, which crossed into humans a small number of times, HIV-2 made the jump on multiple independent occasions, producing at least nine recognized groups (A through I). Research in Côte d’Ivoire has documented a novel HIV-2 variant unrelated to any previously defined group, demonstrating that sooty mangabey viruses continue to cross into humans and cause new zoonotic outbreaks.⁵ HIV-2 progresses more slowly, transmits less efficiently, and has remained largely confined to West Africa.

How the Virus Crossed Into Humans

The standard account, sometimes called the “cut hunter” hypothesis, proposes that a hunter was injured while killing or butchering a chimpanzee infected with SIV, and that blood-to-blood contact allowed the virus to enter the human body. This is biologically plausible: primate SIV can infect human cells, and a deep cut during butchering would provide a direct route. Some researchers, however, have argued that this framing oversimplifies a more complicated reality. A historical-epidemiological critique points out that the “cut hunter” scenario rests on an ecological oversimplification of the many ways humans and chimpanzees interacted in the forests of central Africa during the colonial period.⁶ Bites, scratches, keeping infant apes as pets, and handling primate carcasses over long distances in trade networks all presented opportunities for blood contact. The virus did not need a single dramatic wound; repeated low-level exposures across a population of hunters, traders, and villagers could have produced the same result.

Modern evidence supports the idea that retroviruses continue to cross from primates to humans through these everyday contacts. A study in central Africa found that people who hunt and butcher wild primates are actively becoming infected with simian foamy virus, a different retrovirus carried by non-human primates. The finding confirms that contact with primate blood in natural settings is a real and ongoing route for cross-species viral transfer.⁷

When HIV First Entered Humans

Pinning down the date of the first human infection requires working backward from the genetic diversity of the virus. By comparing how much HIV-1 group M sequences have diverged from one another and calibrating against a molecular clock, researchers estimated that the last common ancestor of all group M strains existed around 1931, with a confidence interval stretching from 1915 to 1941.⁸ A later, more detailed study using a broader set of viral genomes pushed the estimate slightly earlier, placing the common ancestor around 1920 and emphasizing the role of Kinshasa as the city where the virus first took hold.⁹

These molecular estimates have been corroborated by some of the most remarkable forensic work in virology. Researchers recovered HIV-1 sequences from a lymph node biopsy preserved in paraffin wax that had been taken from a woman in Léopoldville (now Kinshasa) in 1960. The virus in that sample was already substantially divergent from other early HIV-1 sequences, proving that the virus had been diversifying in the human population for decades before anyone knew it existed.¹⁰ Even more impressively, a team later screened 1,645 preserved tissue specimens collected in Central Africa between 1958 and 1966, recovering a near-complete HIV-1 genome from a 1966 Kinshasa sample. That virus turned out to be a nonrecombinant lineage related to modern subtype C, making it the oldest near-full-length HIV-1 genome ever obtained.¹¹ Together, these archival findings confirm that HIV-1 was circulating and diversifying in Kinshasa well before the AIDS epidemic was recognized in the 1980s.

Why Kinshasa Became Ground Zero

Crossing from a chimpanzee to a single human was not enough to start a pandemic. SIV probably entered isolated individuals many times over centuries without going anywhere. For group M to explode, the virus needed a setting where it could transmit rapidly from person to person and build up enough genetic diversity to become well-adapted to human biology. Kinshasa in the early-to-mid twentieth century provided exactly that environment, through a convergence of factors that no one at the time could have anticipated.

The city grew explosively under Belgian colonial rule. Léopoldville was a colonial administrative center and transportation hub, and its railways connected it to vast stretches of central Africa. By the late 1940s, over a million people were passing through the city’s rail network every year. This movement gave a locally circulating virus access to distant populations, seeding new chains of transmission across the region. Phylogenetic reconstructions of HIV-1’s early spread emphasize these transport networks as a critical factor in the virus’s establishment in human populations.⁹

The city also had a severe gender imbalance. Colonial labor policies drew large numbers of men into urban areas while leaving women behind in rural villages. Through the 1930s and 1940s, the adult male-to-female ratio in Léopoldville fluctuated between three-to-one and four-to-one, a disparity that colonial authorities themselves recognized as fueling commercial sex work.¹² The resulting sexual networks created conditions for rapid spread of sexually transmitted infections, and the city experienced severe epidemics of syphilis, chancroid, and lymphogranuloma venereum. Observational studies have estimated that sexually transmitted infections producing genital ulcers can raise the efficiency of HIV transmission roughly two-to-fourfold.¹³ The peak of these genital ulcer diseases in Léopoldville coincides with the period when phylogenetic analysis places the initial diversification of pandemic HIV-1.¹⁴

On top of all this, colonial public health campaigns introduced large-scale medical interventions that involved the reuse of syringes and needles. Campaigns against sleeping sickness, yaws, and other tropical diseases injected enormous numbers of people with equipment that was rarely sterilized between patients. This created a direct blood-to-blood transmission route that could have amplified what would otherwise have been sporadic infections. Research examining the growth of unsterile injections in Africa, particularly during the 1950s and 1960s, has proposed that serial passage of partially adapted SIV through humans via contaminated needles could have generated the cumulative mutations needed for the virus to become efficiently transmissible.¹⁵ A review of these narratives places the relevant period of unsafe medical practices between 1880 and 1940, overlapping squarely with the molecular estimates of when HIV arose.¹⁶

The Path to the Americas

For decades, the story of HIV in the United States was entangled with the myth of “Patient Zero,” a Canadian flight attendant named Gaëtan Dugas who was blamed for introducing the virus to North America. Genetic analysis has thoroughly debunked that narrative. The virus was circulating in the United States well before Dugas could have played any such role.

The actual route was more circuitous and began in Central Africa. Using HIV-1 gene sequences recovered from archival samples of some of the earliest known Haitian AIDS patients, researchers determined that subtype B, the strain dominant in the Americas and Europe, moved from Africa to Haiti around 1966. It circulated there for several years before a single migration event carried it out of Haiti and into the United States around 1969.¹⁷ The connection was probably through Haitian professionals who had worked in the newly independent Democratic Republic of the Congo during the 1960s and then returned home. From the United States, subtype B spread globally. The vast majority of non-Haitian subtype B infections worldwide trace back to that single dispersal event from Haiti.

The Oral Polio Vaccine Theory and Why It Was Wrong

In the late 1990s, a controversial book proposed that HIV entered humans through contaminated oral polio vaccines prepared using chimpanzee kidney cells and administered in Central Africa during the late 1950s. The hypothesis attracted intense public attention but has been decisively refuted on multiple fronts. Laboratory analysis of frozen samples of the suspect vaccine stocks failed to detect either HIV-related genetic material or chimpanzee DNA, ruling out the possibility that chimpanzee cells were used in their preparation.¹⁸ Separately, researchers surveyed wild chimpanzees in the region where the vaccine trials took place and found that while SIV was indeed present in local chimpanzees, the circulating virus was phylogenetically distinct from all known strains of HIV-1. The chimpanzees in that area could not have been the source of the pandemic.¹⁹ The molecular clock evidence, placing HIV’s common ancestor decades before the vaccine trials began, further undermined the timeline the hypothesis required.

How SIV Overcame Human Defenses

Jumping between species is not easy for a virus. Human cells carry built-in antiviral proteins that block foreign retroviruses, and SIV had to evolve ways around those defenses before it could replicate efficiently in people. Three of the best-studied restriction factors are APOBEC3G, TRIM5α, and tetherin, each of which attacks a different stage of the viral life cycle.²⁰ HIV-1 has evolved specific countermeasures against each one. Its Vif protein neutralizes APOBEC3G, and its Vpu protein counteracts tetherin, the protein that otherwise traps newly formed virus particles on the cell surface.

Interestingly, the transmembrane region of tetherin is nearly identical in humans, chimpanzees, and gorillas, which helps explain why viruses circulating in apes were preadapted to deal with the human version.²¹ By contrast, the same region differs substantially between apes and monkeys, which partly explains why monkey-origin SIVs do not readily infect humans. Group M’s Vpu appears to have been unusually effective at antagonizing human tetherin, and some researchers suspect this contributed to its pandemic success compared to the other groups.

A Genetic Shield Some Humans Carry

While most of the origin story focuses on the virus, human genetics also shaped who got infected and how quickly the virus spread. A mutation in the CCR5 gene, called CCR5-delta32, alters one of the receptors HIV uses to enter cells. People who carry two copies of this mutation (homozygotes) are strongly protected against HIV-1 infection. A meta-analysis found that homozygous carriers had roughly a 75 percent reduction in infection risk compared to non-carriers.²² Among people with documented exposure to the virus who remained uninfected, carriers of the delta32 variant also had significantly reduced risk. The mutation is most common in people of Northern European descent, where it reaches frequencies of around 10 percent, and is extremely rare in African and East Asian populations. Its geographic distribution means it played no meaningful role in shaping the early African epidemic, but it has been an important clue in understanding HIV biology and became the basis for a celebrated cure: the “Berlin patient,” who was transplanted with bone marrow from a CCR5-delta32 homozygous donor and cleared the virus.

The Deep Evolutionary History of Primate Lentiviruses

HIV’s emergence in the twentieth century might seem like a freak recent event, but the family of viruses it belongs to has been circulating in primates for an extraordinarily long time. Traditional phylogenetic methods, which compare viral sequences and assume a steady mutation rate, tended to date primate lentiviruses to only a few hundred years ago. That estimate turned out to be far too recent. Analysis of ancient marks left by lentiviruses in primate genomes suggests that ancestors of modern SIV existed in simian primates more than 10 million years ago.²³ A more recent unified analysis estimated that the most recent common ancestor of all known SIV strains dates to roughly one million years ago, and that the specific lineages giving rise to HIV-1 and HIV-2 have been circulating in their chimpanzee and mangabey hosts for tens to hundreds of thousands of years.²⁴

This deep history has a striking implication: humans living alongside these primates were exposed to SIV for millennia before HIV emerged. The virus crossed into individual humans many times over that span and almost certainly failed to gain a foothold each time. What changed in the twentieth century was not the virus itself but the human world around it. Urbanization, colonial labor systems, medical campaigns with reusable needles, and dense sexual networks gave a poorly adapted primate virus the transmission opportunities it needed to evolve into a human pathogen. Without those amplifiers, the spillover that eventually produced group M would likely have fizzled out like every one before it.

Spillover Has Not Stopped

It would be comforting to treat HIV’s origin as a closed chapter, but the underlying conditions for new zoonotic transmission have not disappeared. People across Central and West Africa continue to hunt, butcher, and consume wild primates, exposing themselves to primate retroviruses. The discovery of ongoing simian foamy virus infections in central African hunters confirmed that retroviral cross-species transfer is not a historical curiosity but a present-day reality.⁷ The identification of a brand-new HIV-2 lineage in rural Côte d’Ivoire, unrelated to any previously known HIV-2 group, underscores the point even more forcefully: sooty mangabey viruses are still making the jump.⁵

Surveillance programs are attempting to get ahead of the next spillover rather than responding after the fact. Geospatial modeling of global bushmeat activities aims to identify regions where human-wildlife contact is most intense and where monitoring for novel pathogens would be most productive.²⁵ Whether those programs receive the sustained funding and political support they need remains an open question. The history of HIV demonstrates that novel pandemic viruses do not require exotic laboratory accidents or unusual circumstances. They require ordinary human activities, an unlucky viral mutation or two, and a social environment that allows chains of transmission to lengthen before anyone notices something is wrong.